Vendor Checklist: How to Vet AI Health Tools for Document Security and Non-Training Data Guarantees

AI health tools can save operations teams hours, but they also create a new kind of vendor risk: sensitive health data entering systems that may be connected to analytics, support, advertising, or model improvement. Recent coverage of OpenAI’s ChatGPT Health launch underscored the core issue: vendors may promise separate storage and no training use, yet buyers still need to verify the details in contracts, security documents, and privacy policies. If your team is evaluating an AI health vendor, the question is not just whether the product works, but whether the vendor can prove data segregation, non-training commitments, and breach readiness across the full lifecycle of the data.

This guide is a practical vendor vetting checklist for operations, compliance, procurement, and security teams. It focuses on the questions that matter most: does the vendor use your data for model training, how is health data isolated from other customer data, is there a valid business associate agreement, how fast do they notify you after an incident, and do they keep health data separate from advertising systems and “memories” or profile-based personalization. For teams building structured review processes, think of this as the healthcare equivalent of a disciplined procurement review, similar to how companies approach regulatory changes for tech companies or a rigorous AI governance review in lending.

1. Start with the real risk: AI health data is not ordinary input

Why health data changes the vendor bar

Health information is more sensitive than ordinary business data because it can reveal diagnoses, medication use, mental health history, family conditions, and insurance details. Even if the tool is not a regulated medical device, it still creates exposure if it touches protected health information, combines it with identity data, or stores it in a way that is accessible to support staff or subprocessors. That is why the strongest vendors treat health workflows differently from general chat or content-generation features, much like operators treat voice message data protection or sensitive documents with extra controls.

What operations teams should care about most

The practical concern is not theoretical “AI risk” but document security risk: intake forms, lab results, claims attachments, care coordination notes, onboarding packets, and eligibility records can be copied into prompts, stored in logs, or reused in ways your team never intended. If the vendor does not clearly separate customer data, human review data, telemetry, and model improvement pipelines, you may end up with an accidental sharing problem. This is similar to vendor due diligence in other high-stakes systems, where teams assess hidden risk in the same way they might inspect intrusion logging controls or review algorithm resilience when platforms change rules.

Build the review around use case, not hype

Before you compare vendors, define the exact workflow you are buying: document extraction, intake classification, secure summarization, patient communications, prior authorization support, or internal knowledge search. Vendors often overstate “healthcare readiness” while actually offering a generic model wrapped in a UI. A good procurement team narrows the use case first, then tests whether the vendor’s claims about model training guarantees, retention, and segregation are real under that specific workload.

2. The vendor vetting checklist: the 12 questions that matter

Question 1: Will our data be used for model training?

This should be a direct yes-or-no question. The answer must cover prompts, uploads, attachments, transcripts, embeddings, feedback clicks, and any derived data used to improve a model. A trustworthy vendor will say whether customer content is excluded by default, whether opt-out is available, and whether this promise applies to all products or only certain enterprise tiers. If the contract does not expressly state model training guarantees, treat the answer as incomplete.

Question 2: Is health data segregated from other customer data?

Segregation means more than a marketing statement. Ask whether health data is stored in separate logical partitions, whether encryption keys are separate, whether access rights are scoped by tenant and by data class, and whether health data is excluded from general analytics or product experimentation. Strong segregation matters because even a no-training promise can be undermined if a vendor mixes health inputs into shared observability pipelines or cross-product memory features. This is where data segregation becomes a real technical requirement, not just a policy claim.

Question 3: Will the vendor sign a Business Associate Agreement?

If the vendor will create, receive, maintain, or transmit protected health information on your behalf, a business associate agreement is often essential. The BAA should describe permitted uses and disclosures, breach obligations, subcontractor controls, and termination rights. Some vendors avoid BAAs for certain consumer-grade products, which may be a sign that the service is not appropriate for regulated workflows. Treat refusal to sign a BAA as a hard stop unless your counsel confirms the product never touches PHI.

Question 4: How fast is breach notification and what is included?

Operations teams often focus on “whether” a vendor notifies and forget to test “how soon” and “what they include.” The best agreements define notification timelines, typically measured in hours or business days, and specify whether the vendor will provide incident scope, affected records, root-cause summary, mitigation steps, and forensic support. A vague promise to “notify without unreasonable delay” is weaker than a structured process. If a vendor cannot explain its breach notification workflow in plain language, assume incident response maturity is limited.

Question 5: Are health conversations separated from advertising and personalization systems?

This question matters more than ever as AI companies look for monetization opportunities. You want confirmation that health data is not used to target ads, build commercial profiles, or influence unrelated recommendations. If the vendor has consumer features, ask whether health prompts are excluded from memory systems, whether ad-tech partners can see any health-derived signals, and whether user-level personalization is bounded by the health workflow. OpenAI’s ChatGPT Health launch made this concern public, because campaigners warned that separation between health data and broader account memory must be “airtight.”

Question 6: What is the retention period and deletion path?

Vendors should state how long data is kept, what is retained in logs, and how deletion requests work. Pay attention to backups, disaster recovery replicas, and support tickets because data often survives in places buyers forget to ask about. Your team should require a clean deletion path for active records and a written explanation of what cannot be immediately purged. This is the same discipline used when assessing identity verification vendors or other data-heavy systems.

Question 7: Who can access the data internally?

Ask whether employees can access customer content by default, whether access is role-based, whether privileged access is logged, and whether human reviewers are used for QA or safety. If human review exists, ask where reviewers are located, what they can see, and whether they are permitted to copy data into downstream systems. This is where the best teams cross-check the vendor’s answers against SOC 2 reports, internal policies, and public documentation.

Question 8: What subprocessors touch the data?

Modern AI vendors rely on cloud providers, support tooling, analytics vendors, and content moderation services. Request a current subprocessor list and confirm whether any subprocessors are outside the regions you require. You should also ask how the vendor flows down BAA terms and security obligations to those providers. A strong answer shows the vendor understands that privacy policy review is not just about the first-party company, but the whole processing chain.

Question 9: What data is captured in telemetry and logs?

Telemetry can include prompts, file names, error outputs, metadata, IP addresses, and user identifiers. The vendor should be able to say exactly what is logged, how long logs are stored, who can access them, and whether logs are excluded from model improvement. This is one of the most common places where “no training” promises become blurry. If the logging story is vague, the safer assumption is that the vendor is still operationally learning from customer data in some form.

Question 10: How does the vendor handle user prompts with identifiers?

Health documents often contain names, dates of birth, insurance IDs, claim numbers, and provider details. Ask whether the vendor offers redaction, automatic field masking, or tokenization before data enters the model layer. Strong vendors support structured intake patterns that reduce exposure, similar to how teams design secure medical records intake workflows to separate what is necessary from what is not.

Question 11: Are audit logs exportable to your SIEM?

For operational control, you need audit logs that can be exported to security tools and retained for your own investigations. Logs should capture access, changes, admin actions, exports, sharing events, and policy changes. If the vendor cannot support that, you may be blind during an incident. Good logging practices mirror the broader security posture used in systems that emphasize enhanced intrusion logging.

Question 12: What happens if the vendor changes terms?

AI vendors change privacy policies, terms of service, and product features frequently. You need contract language that requires advance notice for material changes, gives you the right to reject changes that weaken privacy commitments, and allows data export and termination without penalty if the changes are unacceptable. This is especially important if the vendor later introduces advertising, memory features, or consumer cross-product tracking.

3. A practical comparison table for procurement and security review

Use the table below as a scorecard during your vendor vetting process. Assign each category a pass, partial, or fail based on written evidence rather than a sales call promise. In regulated environments, the most defensible decision is the one backed by contract language, policy documentation, and security artifacts.

For teams buying tech that touches regulated workflows, it helps to compare these criteria the same way finance teams compare custody controls or security teams compare encrypted platforms. Articles like custody controls for institutional wallets show the value of contractual clarity, while broader IT teams can borrow methods from migration playbooks that turn abstract risk into checklists.

4. How to read the privacy policy like a buyer, not a lawyer

Look for training exclusions and opt-outs

Privacy policies often hide key promises in broad phrases such as “improve our services” or “develop new features.” Your job is to identify whether that language includes customer content, metadata, and support interactions. If the vendor says it does not train on your data, confirm whether that is a default setting, a tier-specific feature, or just a revocable promise. A true enterprise-ready answer is explicit, durable, and reflected in the contract.

Check for advertising and third-party sharing language

Look closely at clauses covering “marketing,” “partners,” “business purposes,” and “personalization.” The policy should say health data is not used to target ads, build consumer profiles, or send data into ad measurement ecosystems. If the vendor’s commercial model depends on advertising, you should require extra proof that health workflows are isolated from monetized surfaces. The concern raised around OpenAI’s consumer business model is a useful reminder that privacy policy review has to include business-model analysis, not just data-flow analysis.

Compare the policy to the product UI

One of the best due-diligence habits is to compare policy language with actual product settings. If the product has memory, history, sharing, and connected-app features, test whether health-related conversations can be excluded from those systems. If the UI makes it hard to separate sensitive inputs from general account behavior, the vendor may be placing too much burden on users to avoid accidental exposure. A strong privacy posture makes the safe path the default path.

5. Security controls that should be non-negotiable

Encryption, access control, and tenant isolation

At minimum, the vendor should use encryption in transit and at rest, role-based access controls, MFA for admins, and tenant isolation for customer data. Ask whether customer-managed keys are available, whether access is time-bounded for support, and how privileged sessions are recorded. If the vendor handles attachments, confirm that uploaded medical records are scanned safely and stored in a protected environment. For teams already comparing secure workflow tools, the standard should feel closer to enterprise document control than to consumer chat.

Auditability and incident response

The vendor should be able to show you how they detect anomalous access, how they investigate unusual exports, and what evidence they can provide after a breach. Ask for sample incident response timelines and post-incident report structures. Mature vendors have playbooks that are boring in the best way: clear responsibilities, fast containment, and concise communication. If you need a reference point, think about the rigor expected in regulated AI governance and the accountability standards in corporate accountability debates.

Subprocessor governance and international data flows

If the vendor uses subcontractors or stores data across regions, you need clarity on jurisdiction, transfer mechanism, and access controls. Global deployment can be fine, but only if the vendor can explain where data lives and who can lawfully reach it. Many teams overlook this until procurement is nearly complete, then discover an issue with residency, transfer, or third-party support access. That delay is expensive, especially when rollout plans depend on fast onboarding and secure approvals.

6. Due diligence workflow for operations teams

Step 1: Send a structured questionnaire

Start with a vendor questionnaire that forces precise answers. Include separate sections for training use, data segregation, breach notification, retention, security controls, subprocessors, and advertising separation. Do not accept marketing language in place of facts. If you are already running vendor review processes for other categories, this can slot into your standard operating model alongside reviews like AI-enabled identity verification or workflow automation tools.

Step 2: Request proof, not promises

Ask for the latest SOC 2 report, pen test summary, incident response overview, subprocessors list, privacy policy, data retention schedule, and BAA template. If the vendor refuses to share artifacts, decide whether the product is suitable for regulated data at all. A sales demo can show capability, but only documents can show accountability. This is the same buyer logic used when teams compare policy-heavy sectors like tax compliance in highly regulated industries.

Step 3: Test the product with sanitized data

Run a controlled pilot using de-identified or synthetic records where possible. Try uploads, chat prompts, exports, deletions, and admin controls. Verify whether logs expose content, whether memory features can be disabled, and whether support can access sample records without unnecessary exposure. Good pilots reveal the gap between a vendor’s promise and its actual configuration.

Step 4: Get legal and security sign-off together

Do not let legal review happen in isolation from security review. A privacy-friendly policy with weak technical controls is still risky, and a secure platform without the right agreement terms can still be noncompliant. The best outcome is a joint sign-off that ties product usage, contract terms, and workflow boundaries together. This collaborative approach is especially important when health documents are connected to onboarding, claims, or care coordination workflows.

7. Red flags that should stop the deal

Ambiguous training language

If the vendor says it “may use data to improve the service” but refuses to define whether that includes model training, stop and escalate. Ambiguity is not a harmless drafting issue in health contexts. It is an indicator that the vendor has not aligned product design, legal language, and customer commitments. If they cannot be precise now, they may not be precise later.

No BAA, no clear retention, no incident timeline

Any one of these gaps should slow procurement; two or more should usually end the evaluation. A vendor that cannot commit to a BAA, cannot explain deletion, and cannot name a breach-notification timeline is not ready for sensitive health data. That is especially true for teams handling intake documents, patient communications, or internal support summaries. In those situations, your operational risk is too high to rely on vague assurances.

Cross-use with advertising or memory features

If health data can flow into advertising, personalization, or memory systems, the product is probably not appropriate for regulated workflows. Consumers may accept that tradeoff in exchange for convenience, but business buyers should not. The public discussion around AI health products is moving quickly precisely because the line between helpful personalization and inappropriate reuse is thin. Protect your organization by requiring explicit separation, not implied separation.

Pro Tip: If a vendor’s answer sounds good in a demo but cannot be copied into a contract clause, it is not a real control. Treat every promise as untrusted until it appears in writing and maps to an actual product setting.

8. Scorecard template for final vendor decision

Use a weighted rubric

Give the highest weights to training guarantees, BAA availability, breach notification, and data segregation. Those are the issues most likely to create compliance exposure or unacceptable privacy risk. Secondary weights can cover user experience, integrations, and analytics. A scoring model helps prevent “feature excitement” from overpowering core risk factors.

Recommended weighting

A simple 100-point model works well: 30 points for security and segregation, 25 for legal and contract terms, 20 for data-use promises, 15 for incident response, and 10 for operational fit. If a vendor scores poorly on any one of the non-negotiables, mark it as conditional or reject. That way the team can still compare alternatives without losing sight of the must-have controls.

Document your decision trail

Keep a single folder with the questionnaire, the vendor’s written responses, policy snapshots, redlines, and final approvals. This creates an audit trail and makes future renewals much easier. It also helps if the vendor changes policies later, which happens often in the AI market. Good records turn a one-time procurement into a repeatable governance process.

9. FAQ: common questions from operations and procurement teams

10. Bottom line: buy the control, not the demo

AI health tools can improve intake, summarize records, and speed up workflows, but only if the vendor’s promises survive legal review, technical validation, and operational testing. For buyers, the key is to evaluate the full data path, not just the front-end experience. The right vendor will provide clear answers on model training guarantees, data segregation, BAA terms, breach notification, and advertising separation, and will back those answers with artifacts you can review.

That diligence is not extra work; it is the cost of safely adopting AI in a sensitive environment. The teams that win are the ones that treat privacy policy review, due diligence, and contract negotiation as part of product implementation, not paperwork after the fact. In a market moving as fast as AI health, disciplined vendor vetting is the difference between scalable automation and avoidable risk.

Related Reading

• How to Build a Secure Medical Records Intake Workflow with OCR and Digital Signatures - A practical blueprint for handling sensitive records with stronger intake controls.
• How to Evaluate Identity Verification Vendors When AI Agents Join the Workflow - A buyer’s guide to assessing AI-enabled identity and access workflows.
• Understanding Regulatory Changes: What It Means for Tech Companies - A useful lens for translating policy change into vendor requirements.
• How Upcoming AI Governance Rules Will Change Mortgage Underwriting - Lessons on governance, controls, and documentation in regulated AI.
• Enhanced Intrusion Logging: What It Means for Your Financial Security - Why logging quality matters when data sensitivity is high.